Atlas Trials

Can we Use a Simple Blood Test to Reduce Unnecessary Adverse Effects From Radiotherapy by Timely Identification of Radiotherapy-resistant Rectal Cancers? MeD-Seq Rectal Study

Clinical trial NCT06035471 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06035471
Sponsor
Erasmus Medical Center
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Pathological Response Rate, Circulating Tumour DNA
Start date
2023-10-01
Primary completion
2026-06-01
Enrollment
75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.